Marinus is a commercial stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. Marinus is investigating the potential of ganaxolone, a neuroactive steroid GABAA receptor modulator, in IV and oral formulations to maximize therapeutic reach in acute and chronic care settings. For more information, visit https://marinuspharma.com/
Marinus is a commercial stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. Marinus is investigating the potential of ganaxolone, a neuroactive steroid GABAA receptor modulator, in IV and oral formulations to maximize therapeutic reach in acute and chronic care settings. For more information visit https://marinuspharma.com/